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THE possible existence ofa relationship between thyroid activity and both the
incidence and progress of breast cancer has been the subject of considerable
discussion over a number of years. We reviewed the literature in our paper of
1961, and described the early stages ofan experimental approach we were making
in an attempt to answer the question (Sicher and Waterhouse, 1961). From
papers published since then it is clear that the question is still open and contro-
versial. In the present communication we describe the results of our own work
to date, and discuss briefly some ofthe recent contributions to the subject.-
Questions at issue
More than one type ofrelationship between thyroid function and breast cancer
has been considered in the recent literature, and it is not always clear what is
under investigation in a particular study. The hypothesis that hyperfunction
of the thyroid gland is associated with a reduced incidence of breast cancer is
supported by Humphrey and Swerdlow (1964) who found no case ofbreast cancer
among 196 patients with hyperthyroidism followed for 12 years. Stoll (1962),
however, cannot support the hypothesis from his study of 150 cases of breast
cancer. Capelli and Margottini (1964) failed to detect a decrease in thyroid
function among patients with breast cancer. Humphrey and Swerdlow (1964)
found, among cases of breast cancer having a history of hyperthyroidism, both a
higher 5-year survival rate and a lower incidence oflocal recurrences than among
the remainder oftheir cases ofthe disease.
The last finding mentioned above seems in conflict with that of Edelstyn,
Lyons and Welbourn (1958) that breast cancer patients with only local extensions
of growth had consistently higher indices of thyroid activity than patients in
whom blood-borne spread had occurred. Reeve et al. (1961) reanalysed the data
of Edelstyn et al. (1958) making certain plausible assumptions, and arrived at the
same conclusions, although in a study of their own, using groups of patients
similar to those ofEdelstyn et al., they could showno difference in levels ofthyroid
activity between patients with local disease or with blood-borne metastases.
Similar hypotheses have formed the basis of treatment in cases of breast
cancer. Stoll (1962) in a series of 12 advanced cases treated with a combination
of oestrogen and tri-iodothyronine (T3) could find no evidence for any regression
ascribable specifically to T3. Emery and Trotter (1963) used T3 in a controlled
study of 54 advanced cases without finding evidence of any noticeable effect on
the prognosis. Lyons and Edelstyn (1965) used desiccated thyroid extract and
laterthyroxine in comparison with a control series and again could findno evidence
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of local recurrences in their treated group, which they regarded as in support of
their earlier (1958) postulation ofan association between hyperthyroidism and the
incidence of local rather than distant metastases.
EXPERIMENTAL WORK
In our original study we attempted to assay thyroid function in a group of
women with breast cancer, mainly in the earlier stages of advancement. The
tests were carried out either before or at the initial stage of treatment. We
were seeking also the most useful measure ofthyroid function, and for this purpose
we obtained a number of readings both of uptake by the gland, and of urinary
excretion, oftracer doses of 131I. For reasons we gave at the time we eventually
selected the uptake at the 24th hour, and the excretion from 6 to 24 hours as the
best readings to use. With these measures we found in our series of 119 cases a
slight bias towards hypothyroidism, but no evidence of statistically significant
thyroid dysfunction.
The same method of assessment was repeated after the lapse of 5 years on as
many as possible of the survivors from the original group. In our paper we had
used for the measurement of 131I uptake at the 24th hour the letter " B ": we
continue to use the same letter for this measurement, but describe the initial
results as B1 and the second value as B2. Fig. 1 shows a scatter diagram of B2
against B1 for the 47 cases for which both measurements were available. The
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FrG. 1.-Scatter diagram ofthyroid activity (B2) at 5 years
in relation to initial activity (B1).K. SICHER AND J. A. H. WATERHOUSE
diagonal line on this figure is the line of equality, B2 = B1. Below this line are
points for which B2 is less than B1, and above B2 is greater than B1. Clearly more
points lie below the line-in fact, just over twice as many (32:15)-revealing a
general tendency for a reduction in thyroid activity measured by B. The pre-
ponderance ofpoints below the line is significantly different from an equal division
(P < 0.02), though the difference in the mean values (B2-B1), which is 4 0, just
fails to attain the 5% level of statistical significance (t = 1-93; 5% level is 1.99).
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FIG. 2.-Comparison of methods of asessment ofthyroid activity 1311 uptake
at 24 hours (B2) with protein-boulnd iodine (P.B.I.).
The difference is likely to be due either to the advancement of 5 years in age of
the patients, or it may possibly result from an effect on the thyroid of irradiation
of the supraclavicular fossa. Although a value of B2 was only obtainable if the
patient had survived 5 years from the time B, was obtained, so that the group
under discussion represents a selected sub-sample of the original number of cases
(47 out of 119), the mean B for those who did not survive to yield a B2 value was
38-57 compared with 38-68 for those who did.
Another method of assaying thyroid function was also employed at the time
of the second determination. This was the measurement of protein-bound
iodine (P.B.I.). Fig. 2 shows in a scatter diagram the relationship of P.B.I. to
B2 for the 40 cases for which both measurements were available. The broken
lines sketched on this figure indicate the usually accepted ranges ofnormality for
the 2 indices. There is good general agreement between the 2 methods of assess-
ment, the majority of readings being situated in the area of normality for both.
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One case is above normal in both measurements, another below normal for both
and 2, or possibly 3, are normal for B2 but subnormal for P.B.I. It would thus
appear that the 2 methods of assessment show in these cases a sufficient measure
of agreement to be used interchangeably. From the point of view of the patient
of course, the small blood specimen required for the P.B.I. test represents con-
siderably less inconvenience than what is involved in the measurement ofthyroid
uptake of 131I (" B "). The laboratory determination of P.B.I. from the blood
sample, however, if it is to be reliable and reproducible within reasonable limits
of accuracy, is not a simple matter. We are fortunate in having access to a
laboratory which has made a special study of the method.
VALUE OF ASSESSMENT OF THYROID FUNCTION IN PROGNOSIS
Our original aim was to discover whether thyroid activity bore any relationship
to prognosis in cancer of the breast, and particularly in respect of metastatic
spread. For this purpose we need to use the assessment ofthyroid function made
initially, within a short time of diagnosis. We shall therefore relate the progress
of our series of 119 cases to B1, the initial measure of thyroid activity.
Fig. 3 shows the distribution ofB1 to be an approximately gaussian (" normal ")
pattern. Of the 119 cases, 60 were below 40, and 59 at 40 or above this value.
This point therefore represents very nearly a median split of the data classified
according to B1. It affords a convenient dichotomy of the cases into those of
relatively high or low initial thyroid activity.
At the time ofwriting our first paper 21 cases had already died, for 11 ofwhom
B1 was below 40, and for 10, 40 or above. A further 48 cases died of cancer
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FIG. 3.-Distribution of initial thyroid activity (B1).
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between reporting the 2 investigations, 24 of whom had a value of B1 below 40,
and 24 above. Six cases have died free of the disease, dividing 3 below 40 and 3
above; and of those still alive, 44 in number, in 22 B1 was below 40, and in 22 it
was 40 or more.
Using the value of B1 which divides the series into 2 nearly equal groups, it
is clear that there is a quite extraordinarily close agreement between the progress
and fate ofthe 2 groups. It seems therefore that initial thyroid activity measured
by B1 has little relationship to prognosis. It is however a crude method of
comparison which takes no account ofthe quantitative value ofB1 above or below
40.
Table I shows survival in relation to grouped values of B1, and it also
summarises the survival according to the dichotomy of B1, discussed above.
TABLE I.-Initial Thyroid Status and Survival
Duration of life (years)
5-Year survival
B1 Total 0 1 2 3 4 5+ rate
<10 . 1 1
10-19 . 5 . 1 1 - - -- 3 . 60.0%-
20-29 . 21 . 3 3 4 1 10 . 48-0%
30-39 . 33 . 1 10 3 1 18 . 54.0%
60 2 15 6 4 2 31 . 51-7%
40-49 . 37 . 2 8 2 3 22 . 59.0%
50-59 . 16 . - 2 5 - 1 8 . 50.0%
60-69. 6 2 - 4 . 67-0%
59 . 4 10 7 4 34 . 57.6%
Although the 5-year survival rate has been calculated for each group ofB1 values,
the numbers are small in such a classification andthere is no statistically significant
difference between the rates, nor is any trend discernible. For the division of
the series at the value of 40 for B1, Fig. 4 shows the survival rates by year up to
the 5th. Again there is no real difference between the curves. The fact that both
these curves are atypical for survival experience in the 1st year in particular
reflects merely an initial selection which, as we have pointed out earlier, excluded
advanced cases and those too ill for 131I investigations to be made. Further
evidence ofthe deliberate selection by stage ofadvancement is shown in Table II,
which sets out in a similar way for grouped values of B1 the stage distribution
of cases in the series. The mean stage of the first group (B1 less than 40) is 197,
with a 5-year survival rate of51.7%, and for the second group mean stage is 2-03,
and 5-year survival rate 57-6%. Neither difference is statistically significant.
We have classified according to condition at death the 69 patients who died
within 5 years from the time their B1 value was obtained. Of 50 cases with
distant or widespread metastases, the mean B1 figure was 38-34; of 14 cases with
only local metastases it was 38'2; and for the remaining 5 cases with no evidence
ofmalignancy it was 41-8. Fifty cases survived the 5 years, but 3 refused the B2
determination. Ofthe other 47 (mean B1 = 38-68, mean B2= 34.68) 38 showed
no evidence of malignancy, but 9 had developed secondaries (mean B1 = 42-3,
mean B2 = 35.8). Again, none of these differences is statistically significant.
We are forced to the conclusion, therefore, from the results in our series of
119 cases that the prognosis in breast cancer seems not to be influenced by the
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FIG. 4.-Comparison of survival rates of patients having initial thyroid activity
below median (B1 < 40) with those at median and above (B1 = 40+).
TABLE II.-Initial Thyroid Status and Stage Distribution
Stage
t ~~~~A
B1 1 2 3 4 Total
< 10 . 1 - - . 1 . Mean stage
10-19 . 4 1 - . 5 . = 1-97
20-29 . 4 11 5 1 . 21 . 5-Year survival
30-39 . 11 12 9 1 . 33 . rate
20 24 14 2 . 60 . =51.7%
40-49 . 12 11 10 4 . 37 . Mean stage
50-59 . 8 5 2 1 . 16 . = 2-03
60-69 . 2 3 1 . 6 . 5-Year survival
rate
22 19 12 6 . 59 . =57.6%
level ofthyroid activity determined atthe outsetbythe method wehave described.
We feel that we cannot however regard the matter as conclusively settled on the
basis ofthese results. It may well be that our measure ofactivity is not the best
to use, nor made at the optimum time. Serial measurements, perhaps 6-monthly,518 K. SICHER AND J. A. H. WATERHOUSE
would be likely to yield more valuable information, but could only be entertained
if, like the estimation of P.B.I., they caused a minimum of inconvenience to
patients.
DISCUSSION
The fact that our own results, like so many others in the literature, are incon-
clusive or negative is puzzling in view ofthe strength of clinical impressions to the
contrary. Reeve et al. (1961) suggested a possible explanation of the conflict
between their own findings and those of Edelstyn et al. (1958), which they had
confirmed by re-analysis, which implied that among patients with disseminated
disease there might be a degree of disorganisation in the various measures of
thyroid activity that have been used. We have ourselves suspected that we might
not be using the best indices ofthyroid function, and we were interested to recieve
some support for this view in a communication from Reynolds (1965, personal
communication). Reynolds is attempting to assess the potential functional
activity of the thyroid gland by its response to exogenous stimulation, by deter-
mining the 1311 uptake first before, and then after, the administration of T.S.H.
A normal gland is likely to show a sharp increase in uptake, whereas one that is
already maximally stimulated will not. Whether or not this method will effect
a resolution of the apparent anomalies so far reported can only be decided by
trial, but we hope to be able to extend our own studies in this direction.
SUMMARY
The results of an investigation to assess the influence of thyroid activity on
prognosis in breast cancer are reported. Two measures of thyroid activity have
been used, the uptake at the 24th hour (" B ") oftracer doses of 131I and the assay
of protein-bound iodine (P.B.I.), which are shown to be closely equivalent in
practice. Patients who survived 5 years from an initial measurement of B were
assessed in the same way again, and showed a slight reduction, not statistically
significant, in thyroid activity. In relation to their initial measurements the
actual fate ofpatients 5 years later appeared to show no evidence of the influence
of thyroid activity. This apparently anomalous conclusion, conforming with
others intheliterature, is attributed to thepossible use ofan inappropriate measure
of activity. It is therefore proposed to attempt a measurement of the gland's
potential activity by its response to exogenous stimulation.
We wish to thank Mr. J. D. F. Williams, principal physicist at the Coventry
and Warwickshire Hospital, for undertaking the iodine studies and Miss Molly
Alsop for much secretarial and computational assistance.
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